For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Search Posts
Roll Call
Fireworks Fly
Op-Eds
Recent Research Suggests…
There has been a great deal of ballyhoo this week over the decision by the U.S. Food and Drug Administration to require food products…
News Release
Pharmaceutical Re-Imports Threaten Medical Innovation
Contact for Interviews: Richard Morrison, 202.331.2273 Washington, D.C., July 18, 2003—The Competitive Enterprise Institute is opposing proposals to allow the re-importation of drugs from foreign…
Op-Eds
Rules May Save Fuel but Won’t Save Lives
When it comes to saving fuel, federal Corporate Average Fuel Economy (CAFE) regulations are expensive, cumbersome and insidiously deadly. They force new technologies…
News Release
New! CEI’s Politically Correct Periodic Table Mousepad
Preview of the mousepad available in pdf format. Learn the “new” chemistry from this mousepad guide to…
Op-Eds
Biotech Woes…and the Culprits
<?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />America learned long ago that what's good for General Motors isn't necessarily good for the country.